long actually in the high nines and I've been on record for a long time that the pps will go to .25 if not higher. We actually talked about that when we talked about the RS. .20-.25 cents, there is very little doubt about that. Now, how long will it stay there, I would say not long. Then it will proceed based on Lympro revenue, and milestones in MANF studies and the beginning of the Eltoprazine study.
At some point in the future AMBS could well be worth billions, but we will not know for years.
My comments only have to do with the truth. Frankly, any serious investor of AMBS should know there is next to no market for an AD test. There is only a research market. A blood test will not change that.
Anything anyone writes here will not change that, and the articles regarding the Georgetown test noted that there is no market yet. I did not read the last article regarding the English test carefully.
News 
Market Data 
Discover 
